Literature DB >> 30759002

Cell-based Therapy for Chronic Obstructive Pulmonary Disease. Rebuilding the Lung.

Daniel J Weiss1.   

Abstract

As the prevalence and impact of lung diseases continue to increase worldwide, new therapeutic strategies are desperately needed. Advances in lung-regenerative medicine, a broad field encompassing stem cells, cell-based therapies, and a range of bioengineering approaches, offer new insights into and new techniques for studying lung physiology and pathophysiology. This provides a platform for the development of novel therapeutic approaches. Applicability to chronic obstructive pulmonary disease of recent advances and applications in cell-based therapies, predominantly those with mesenchymal stromal cell-based approaches, and bioengineering approaches for lung diseases are reviewed.

Entities:  

Keywords:  bioengineering; cell therapy; mesenchymal stromal cell

Mesh:

Year:  2018        PMID: 30759002     DOI: 10.1513/AnnalsATS.201808-534MG

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN: 2325-6621


  5 in total

Review 1.  Stem cell therapy for COVID-19 and other respiratory diseases: Global trends of clinical trials.

Authors:  Hong-Long Ji; Cong Liu; Run-Zhen Zhao
Journal:  World J Stem Cells       Date:  2020-06-26       Impact factor: 5.326

2.  Effect of mesenchymal stromal cell infusions on lung function in COPD patients with high CRP levels.

Authors:  Daniel J Weiss; Karen Segal; Richard Casaburi; Jack Hayes; Donald Tashkin
Journal:  Respir Res       Date:  2021-05-08

3.  Allogeneic human umbilical cord-derived mesenchymal stem/stromal cells for chronic obstructive pulmonary disease (COPD): study protocol for a matched case-control, phase I/II trial.

Authors:  Duc M Hoang; Kien T Nguyen; Anh H Nguyen; Bach N Nguyen; Liem Thanh Nguyen
Journal:  BMJ Open       Date:  2021-05-13       Impact factor: 2.692

Review 4.  Stalling SARS-CoV2 infection with stem cells: can regenerating perinatal tissue mesenchymal stem cells offer a multi-tiered therapeutic approach to COVID-19?

Authors:  Sudha Warrier; S Mohana Sundaram; Lavanya Varier; Ananthakrishnan Balasubramanian
Journal:  Placenta       Date:  2021-12-06       Impact factor: 3.481

Review 5.  Targeting Aging Pathways in Chronic Obstructive Pulmonary Disease.

Authors:  Molly Easter; Seth Bollenbecker; Jarrod W Barnes; Stefanie Krick
Journal:  Int J Mol Sci       Date:  2020-09-21       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.